Gelteq Ltd. (GELS) Stock Price, Financials & Summary

Price chart

Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4

Key dataNov 4, 2026

Open$0.48

From 52W high−69.86%

Volume31653.00

Market cap$5.16M

P/E (TTM)—

P/S (TTM)26.4x

Div yield—

Key dataNov 4, 2026

Open

$0.48

From 52W high

−69.86%

Volume

31653.00

Market cap

$5.16M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−2.3x

P/E (TTM)

—

RSI (14)

44.6

MomentumView details →

1D Return

−5.71%

YTD Return

−41.14%

SummaryUpdated Dec 1, 2025

Gelteq Limited (NASDAQ:GELS) is an Australian pharmaceutical technology company founded in 2017 and headquartered in Caulfield, Australia. The company specializes in developing and commercializing innovative gel-based delivery systems for pharmaceutical and consumer health products across both human and animal applications. Since its incorporation, Gelteq has positioned itself as a white-label solutions provider in the drug delivery space, focusing on creating proprietary gel formulations that can enhance the effectiveness and user experience of various therapeutic and wellness products.

Ask drillr about Gelteq Ltd. →

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−2.3x

EV/Sales

44.6x

P/S (TTM)

26.4x

P/B (TTM)

0.5x

ProfitabilityView details →

Gross Margin

58.83%

Net Margin

−2526.90%

EBITDA Margin

−1900.96%

ROE (TTM)

−49.88%

ROA (TTM)

−35.20%

Asset Turnover

—

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

+3.93%

EPS CAGR 3Y

—

EBITDA YoY

—

MomentumView details →

1D Return

−5.71%

YTD Return

−41.14%

1Y Return

−55.99%

RSI (14)

44.6

vs 50D SMA

−15.68%

vs 200D SMA

−27.59%

Capital & dividendView details →

Debt/Equity

0.36x

Current Ratio

0.09x

Quick Ratio

0.09x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

280312.00

Net Income (TTM)

−7.08M

Op. CF (TTM)

—

Latest newsMore news →

Gelteq completed veterinary palatability trials with Kemin, validating its Gelteq® technology for animal health applications.145d ago

Gelteq Limited established a new Center of Excellence in Guangdong Province, China, to accelerate product development and commercial expansion.153d ago

Similar companies

Sonoma Pharmaceuticals, Inc.SNOA Universe Pharmaceuticals Inc.UPC RedHill Biopharma Ltd.RDHL Akanda Corp.AKAN PRF Technologies Ltd.PRFX Sunshine Biopharma, Inc.SBFM Find similar companies →

Latest newsMore news →

Gelteq completed veterinary palatability trials with Kemin, validating its Gelteq® technology for animal health applications.145d ago Gelteq Limited established a new Center of Excellence in Guangdong Province, China, to accelerate product development and commercial expansion.153d ago